Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
Clinical trial NCT05873192 · RECRUITING
Trial details
- NCT number
- NCT05873192
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-03
- Primary completion
- 2026-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.